Clinical Trial Update: Multiple Doses Escalation Study of SHR0302 in Rheumatoid Arthritis (RA) Patients [Phase 1]

View source ↗

Summary

A Phase 1 dose-escalation trial update of SHR0302 in rheumatoid arthritis, outlining ongoing activities and enrollment status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• SHR0302 (SHR0302)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Rheumatoid Arthritis | Phase 1 | Status: UNKNOWN